TRCT
CAI

Tower Research Capital (TRC)’s Caris Life Sciences CAI Stock Holding History

Tower Research Capital (TRC)’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.8K Buy
3,299
+3,200
+3,232% +$57.3K ﹤0.01% 2606
2026
Q1 		$1.77K Sell
99
-41
-29% -$896 ﹤0.01% 4604
2025
Q4 		$3.78K Buy
140
+117
+509% +$3.29K ﹤0.01% 4315
2025
Q3 		$696 Sell
23
-2,085
-99% -$66.5K ﹤0.01% 4960
2025
Q2 		$56.3K Buy
+2,108
New +$56.8K ﹤0.01% 2871

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Tower Research Capital (TRC)'s CAI Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Caris Life Sciences (CAI) stake by 3,232% in Q2 2026, buying an estimated $57.3K and bringing the position to 3,299 shares worth $58.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2606.

Tower Research Capital (TRC) first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Tower Research Capital (TRC) held 3,299 shares of Caris Life Sciences worth $58.8K as of Q2 2026.
  • Tower Research Capital (TRC) bought 3,200 Caris Life Sciences shares in Q2 2026, an estimated $57.3K.
  • Caris Life Sciences made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2606 holding.
  • Tower Research Capital (TRC) first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.